AU2001271976A1 - Microspheres and adjuvants for dna vaccine delivery - Google Patents

Microspheres and adjuvants for dna vaccine delivery

Info

Publication number
AU2001271976A1
AU2001271976A1 AU2001271976A AU7197601A AU2001271976A1 AU 2001271976 A1 AU2001271976 A1 AU 2001271976A1 AU 2001271976 A AU2001271976 A AU 2001271976A AU 7197601 A AU7197601 A AU 7197601A AU 2001271976 A1 AU2001271976 A1 AU 2001271976A1
Authority
AU
Australia
Prior art keywords
microspheres
adjuvants
dna vaccine
vaccine delivery
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271976A
Inventor
Tricia Cecil
Lawrence Evans
Mark E. Johnson
Sally Mossman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001271976A1 publication Critical patent/AU2001271976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2001271976A 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery Abandoned AU2001271976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21660400P 2000-07-07 2000-07-07
US60216604 2000-07-07
PCT/US2001/021780 WO2002003961A1 (en) 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery

Publications (1)

Publication Number Publication Date
AU2001271976A1 true AU2001271976A1 (en) 2002-01-21

Family

ID=22807736

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271976A Abandoned AU2001271976A1 (en) 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery

Country Status (6)

Country Link
US (2) US20020032165A1 (en)
EP (1) EP1299087A1 (en)
JP (1) JP2004502721A (en)
AU (1) AU2001271976A1 (en)
CA (1) CA2414926A1 (en)
WO (1) WO2002003961A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139356A1 (en) 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030108565A1 (en) 2001-07-10 2003-06-12 Johnson Mark E. Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
CA2477191A1 (en) * 2002-02-04 2003-08-28 Sally Mossman Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
US7094410B2 (en) 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
US6923958B2 (en) 2002-03-02 2005-08-02 The Scripps Research Institute DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
JP4868739B2 (en) * 2002-05-06 2012-02-01 アルナイラム ファーマシューティカルズ， インコーポレイテッド Nucleic acid delivery methods
GB0228689D0 (en) * 2002-12-09 2003-01-15 Elan Drug Delivery Ltd Compositions
US7053783B2 (en) 2002-12-18 2006-05-30 Biovigilant Systems, Inc. Pathogen detector system and method
WO2004060396A2 (en) 2002-12-27 2004-07-22 Chiron Corporation Immunogenic compositions containing phospholpid
CN100387301C (en) * 2003-05-12 2008-05-14 佛罗里达大学研究基金公司 Materials and methods for immunizing against fiv infection.
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
SE527505C2 (en) * 2003-06-10 2006-03-28 Anna Imberg Composite materials and particles
CN100595564C (en) * 2004-07-30 2010-03-24 百维吉伦特系统有限公司 Pathogen and particle detector system and method
CN101223560B (en) * 2005-07-15 2012-12-12 百维吉伦特系统有限公司 Pathogen and particle detector system and method
US8628976B2 (en) * 2007-12-03 2014-01-14 Azbil BioVigilant, Inc. Method for the detection of biologic particle contamination
WO2014052875A1 (en) * 2012-09-27 2014-04-03 Cynvenio Biosystems, Inc. Stimulus-sensitive microparticles and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471036B2 (en) * 1989-05-04 2004-06-23 Southern Research Institute Encapsulation process
EP1837017A3 (en) * 1997-01-22 2009-12-23 Eisai Inc. Microparticles for delivery of nucleic acid
US6048551A (en) * 1997-03-27 2000-04-11 Hilfinger; John M. Microsphere encapsulation of gene transfer vectors
US6197229B1 (en) * 1997-12-12 2001-03-06 Massachusetts Institute Of Technology Method for high supercoiled DNA content microspheres
GB9810236D0 (en) * 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents

Also Published As

Publication number Publication date
WO2002003961A1 (en) 2002-01-17
US20040009941A1 (en) 2004-01-15
JP2004502721A (en) 2004-01-29
CA2414926A1 (en) 2002-01-17
EP1299087A1 (en) 2003-04-09
US20020032165A1 (en) 2002-03-14
WO2002003961B1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU5532601A (en) Targeted vaccine delivery systems
AU2002347308A1 (en) Secure collection and delivery system
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
MXPA03002453A (en) Use of immidazoquinolinamines as adjuvants in dna vaccination.
AU2001272879A1 (en) Secure and reliable document delivery
AU2001252458A1 (en) Molecular antigen arrays and vaccines
AU2001271976A1 (en) Microspheres and adjuvants for dna vaccine delivery
AU1591402A (en) Vaccine
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
EP1461441A4 (en) Flavivirus vaccine delivery system
GB0014288D0 (en) Vaccine
AU2002210407A1 (en) Therapeutic vaccine formulations containing chitosan
IL189736A0 (en) Vaccine adjuvants
AU1738201A (en) Adjuvants for nucleic acid vaccines
EP1490396A4 (en) Immunogenic hiv peptides for use as reagents and vaccines
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
AU4957800A (en) Vaccine against isa virus
AU2002327959A1 (en) Adjuvants for nucleic acid vaccines
AU2002347346A1 (en) Dna vaccine
AU2002315309A1 (en) Vaccine against tuberculosis
AU2001288795A1 (en) Eia vaccine and diagnostic
GB0003082D0 (en) Vaccine

Legal Events

Date Code Title Description
BG Complete specifications treated as provisional specifications, section 37

Ref document number: PR643001

Country of ref document: AU